Evaluation of cell‐free DNA accuracy as diagnostic biomarker for prostate cancer: A systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Evaluation of cell‐free DNA accuracy as diagnostic biomarker for prostate cancer: A systematic review and meta‐analysis

Published:2021-04-15 Issue: Volume: Page:
ISSN:0885-4513
Container-title:Biotechnology and Applied Biochemistry
language:en
Short-container-title:Biotechnology and Applied Biochemistry

Author:

Chen Caixia¹^ORCID,Chen Chunfeng²,Sadeghi Morteza³

Affiliation:

1. Department of Laboratory Medicine Henan Provincial People's Hospital Zhengzhou China

2. Department of the Third Affiliated Hospital, Henan University of Traditional Chinese Medicine Zhengzhou China

3. Human Genetics Research Center Baqiyatallah University of Medical Sciences Tehran Iran

Publisher

Wiley

Subject

Process Chemistry and Technology,Drug Discovery,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,General Medicine,Bioengineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bab.2149

Reference75 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA Cancer J Clin,2018

2. The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study;Andriole GL;J Urol.,2011

3. Trans‐rectal versus trans‐perineal saturation rebiopsy of the prostate: is there a difference in cancer detection rate?;Abdollah F;Urology.,2011

4. A systematic review of the diagnostic accuracy of prostate specific antigen;Harvey P;BMC Urol,2009

5. Diagnostic performance of PCA3 to detect prostate cancer in men with increased prostate specific antigen: a prospective study of 1,962 cases;Crawford ED;J Urol.,2012